...
首页> 外文期刊>Current vascular pharmacology >Endothelial Dysfunction and Inflammatory Markers of Vascular Disease
【24h】

Endothelial Dysfunction and Inflammatory Markers of Vascular Disease

机译:血管疾病的内皮功能障碍和炎症标志物

获取原文
获取原文并翻译 | 示例

摘要

Vascular diseases are the main reason for morbidity and mortality worldwide. As we know, the earlier phase of vascular diseases is endothelial dysfunction in humans, the endothelial tissues play an important role in inflammation, coagulation, and angiogenesis, via organizing ligand-receptor associations and the various mediators' secretion. We can use many inflammatory non-invasive tests (flow-mediated dilatation, epicedial fat thickness, carotid-intima media thickness, arterial stiffness and anklebrachial index) for assessing the endothelial function. In addition, many biomarkers (ischemia modified albumin, pentraxin-3, E-selectin, angiopoietin, endothelial cell specific molecule 1, asymmetrical dimethylarginine, von Willebrand factor, endothelial microparticles and endothelial progenitor cells) can be used to evaluate endothelial dysfunction. We have focused on the relationship between endothelial dysfunction and inflammatory markers of vascular disease in this review.
机译:血管疾病是全世界发病率和死亡率的主要原因。众所周知,血管疾病的早期阶段是人类的内皮功能障碍,内皮组织通过组织配体-受体结合和各种介质的分泌,在炎症、凝血和血管生成中起着重要作用。我们可以使用许多炎症性非侵入性检查(血流介导的扩张、皮脂厚度、颈动脉-内膜中层厚度、动脉僵硬和踝肱指数)来评估内皮功能。此外,许多生物标志物(缺血修饰白蛋白、喷霉素-3、E-选择素、血管生成素、内皮细胞特异性分子 1、不对称二甲基精氨酸、血管性血友病因子、内皮微粒和内皮祖细胞)可用于评估内皮功能障碍。在本综述中,我们重点讨论了内皮功能障碍与血管疾病炎症标志物之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号